AzTrials
AzTrials

Anesthesia TechniquesPCNL-ANES-INFNCT07326670

Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL

An observational study of Anesthesia Techniques and Percutaneous Nephrolithotomy, run by Elazıg Fethi Sekin Sehir Hastanesi at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This observational study aims to compare the effects of spinal and general anesthesia on perioperative systemic inflammatory response in patients undergoing percutaneous nephrolithotomy (PCNL). Read more about this study

Who is it for?
Ages 18 years and older
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Nov 2025to 25 Apr 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The study population consists of adult patients aged 18 years and older who undergo elective percutaneous nephrolithotomy (PCNL) surgery and meet the eligibility criteria. Patients classified as American Society of Anesthesiologists (ASA) physical status I-III are included. All participants receive either spinal or general anesthesia as part of routine clinical practice, and no additional intervention is performed for research purposes.

Who may be able to join

  • American Society of Anesthesiologists (ASA) physical status class I-III
  • Patients aged 18 years and older

Who cannot join

  • American Society of Anesthesiologists (ASA) physical status class IV or V
  • Patients younger than 18 years
  • Active infection or diagnosis of sepsis
  • Malignancy
  • Chronic inflammatory diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus)
  • Use of immunosuppressive therapy
  • Pregnancy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Fethi Sekin City Hospital

    Elâzığ, Elaziğ

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Spinal and General Anesthesia on Systemic Inflammatory Response in Patients Undergoing Percutaneous Nephrolithotomy: Evaluation of SII, SIRI, AISI, NLR, and RDW

This observational study aims to compare the effects of spinal and general anesthesia on perioperative systemic inflammatory response in patients undergoing percutaneous nephrolithotomy (PCNL). Systemic inflammatory indices derived from routine complete blood count parameters, including Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Aggregate Index of Systemic Inflammation (AISI), Neutrophil-to-Lymphocyte Ratio (NLR), and Red Cell Distribution Width (RDW), will be evaluated. Preoperative and postoperative laboratory values will be analyzed to determine whether the type of anesthesia influences systemic inflammatory markers and related clinical outcomes.

Keywords
Percutaneous nephrolithotomy, Spinal anesthesia, Neutrophil-to-lymphocyte ratio, Red cell distribution width, Systemic inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07326670
Study groupRoleWhat they receive
Spinal Anesthesia GroupPatients undergoing percutaneous nephrolithotomy under spinal anesthesia as part of routine clinical practice. No additional intervention is performed for the purposes of the study.
General Anesthesia GroupPatients undergoing percutaneous nephrolithotomy under general anesthesia as part of routine clinical practice. No additional intervention is performed for the purposes of the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perioperative change in systemic inflammatory indices (SII, SIRI, AISI, NLR, RDW)

    Changes in Systemic Immune-Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Aggregate Index of Systemic Inflammation (AISI), Neutrophil-to-Lymphocyte Ratio (NLR), and Red Cell Distribution Width (RDW) will be evaluated using routine complete blood count parameters obtained preoperatively and postoperatively.

    Measured: From preoperative period (within 6 hours before surgery) to postoperative period (6-24 hours after surgery)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2026
  2. Study start7 Nov 2025
  3. Primary completion25 Apr 2026
  4. Study completion25 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07326670
Sponsor's protocol ID
PCNL-ANES-INFLAM-2025
Acronym
PCNL-ANES-INF
Status last verified
Jun 2026
First submitted
24 Dec 2025
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anesthesia Techniques and Percutaneous Nephrolithotomy, run by Elazıg Fethi Sekin Sehir Hastanesi at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perioperative change in systemic inflammatory indices (SII, SIRI, AISI, NLR, RDW) (time frame: From preoperative period (within 6 hours before surgery) to postoperative period (6-24 hours after surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in